sars-cov-2

Documents about sars-cov-2

• To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.#844030ClinicalTrials.gov
• Fostamatinib for Hospitalized Adults With COVID-19#847040ClinicalTrials.gov
• Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication#849531ClinicalTrials.gov
• Outpatient Treatment With CoVid-19 With Prexablu#870215ClinicalTrials.gov
• suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19#874179ClinicalTrials.gov
• Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients#879514ClinicalTrials.gov
• Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)#881365ClinicalTrials.gov
• Mortalidad en pacientes con enfermedad renal crónica estadío 5 hospitalizados con infección por SARS-CoV-2 entre abril 2020 a octubre 2022 en el Hospital Nacional Cayetano Heredia#251845Repositorio Universidad Peruana Cayetano Heredia
• Evaluación de la asociación de la mutación d614g en el genoma de sars-cov-2 y la presencia de disfunciones quimiosensoriales en pacientes con covid-19 en lima, 2021-2022#270309Repositorio Universidad Peruana Cayetano Heredia
• High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger#354069HAL (France)
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)#855179ClinicalTrials.gov
• Fluvoxamine for Adults With Mild to Moderate COVID-19#858210ClinicalTrials.gov
• Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)#859586ClinicalTrials.gov
• First Case of 2019 Novel Coronavirus in the United States#6217OpenAlex
• SARS-CoV2 (Covid-19), Sociedad, y Cobertura Universal en Salud en México. Vulnerabilidades, Cambio y Pandemia#192308Zenodo (CERN)
• Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)#441950ClinicalTrials.gov
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine#6918OpenAlex
• Occupational risk factors for depression and anxiety symptoms: Insights from a large cohort study during and after the SARS-CoV-2 pandemic.#14992NCBI PubMed Central
• Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates#132279Unpaywall
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19#136411ClinicalTrials.gov
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults#148564ClinicalTrials.gov
• SARS-CoV-2 Nsp1 suppresses the canonical NF-κB pathway by promoting ubiquitin-dependent degradation of TAK1 kinase#159607Unpaywall
• Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)#174946ClinicalTrials.gov
• Eastern Mediterranean Regional (EMR) respiratory virus activity – weekly update: week 15/2026#181154WHO IRIS
• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort.#242355NCBI PubMed Central
• Frajese parla a "Non è L'Arena" 19/01/2022#246979Internet Archive OAI Repository
• Probiotics at war against viruses : what is missing from the picture?#278026SUNScholar
• Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors#284227HAL (France)
• Nanobodies against the S2 region of the spike protein potently neutralize SARS-CoV-2 viruses and show resistance to virus escape#291337Europe PMC
• Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19#321544ClinicalTrials.gov
• A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom#356519ClinicalTrials.gov
• A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years#363661ClinicalTrials.gov
• Microfluidic-optical integrated portable platform with handheld pump for wash-free plasmonic detection of thrombin and SARS-CoV-2 spike protein.#382539NCBI PubMed Central
• Structural and Computational Insights into the Attenuated Innate Immune Recognition of the SARS-CoV-2 N15 Lineage, an Early-Pandemic Variant.#427694NCBI PubMed Central
• At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study#451040Semantic Scholar
• High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.#457471NCBI PubMed Central
• Análise epidemiológica de pacientes internados por infecção do SARS-CoV-2 no estado de Sergipe#469652Repositório Institucional da Universidade Federal de Sergipe
• Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older#471508ClinicalTrials.gov
• Discovery of two novel small-molecule series with potent SARS-CoV-2 inhibition via putative nsp13 open-state trapping.#613406NCBI PubMed Central
• Early HHV-6 IgG and IgA responses during acute SARS-CoV-2 infection in relation to long COVID: a multicohort observational study.#659526NCBI PubMed Central
• A Dual-Membrane Biomimetic Nanoplatform Enables Triple-Modal Therapy Against SARS-CoV-2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi.#671328NCBI PubMed Central
• Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience#779273Bielefeld Pub
• Eastern Mediterranean Regional (EMR) respiratory virus activity - weekly update: week 34/2026#786437WHO IRIS
• COVID-19 Associated Lymphopenia Pathogenesis Study in Blood#801768ClinicalTrials.gov
• Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19#807895ClinicalTrials.gov
• Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning#827639ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19#843284ClinicalTrials.gov
• ACT-20 in Patients With Severe COVID-19 Pneumonia#843512ClinicalTrials.gov
• DIgital Online SuPport for COVID-19 StrEss#850275ClinicalTrials.gov
• Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)#858179ClinicalTrials.gov